Across TCGA pan-cancer cohorts, PRSS29P RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of PRSS29P’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where PRSS29P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types PRSS29P is over-expressed in tumor, although a few such as BLCA show the opposite, repressed pattern.

THCA, BRCA, and KIRP are the cancer types where PRSS29P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in PRSS29P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	All	III,IV	+0.045	.003	7	view →
BRCA	Female	II,III,IV	+0.184	<.001	6	view →
KIRP	All	III,IV	+0.090	.001	5	view →
BLCA	Female	III,IV	−0.064	.004	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: PRSS29P RNA expression & survival · all PRSS29P data types